UBS O'Connor’s 89bio ETNB Stock Holding History

UBS O'Connor’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-52,500	Closed	-$9.19K	–	603
2023 Q1	$9.19K	Buy	+52,500	New	+$685K	﹤0.01%	598

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

UBS O'Connor's ETNB Position: Q2 2024 in Review

UBS O'Connor sold out of 89bio (ETNB) in Q2 2024, closing a stake of 35,962 shares — an estimated $419K sold.

UBS O'Connor first reported a position in ETNB in Q3 2022 and held it in 6 quarters. The position peaked at $1.59M in Q2 2023. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

UBS O'Connor reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
UBS O'Connor sold 35,962 89bio shares in Q2 2024, an estimated $419K.
UBS O'Connor first reported a position in 89bio in Q3 2022 and held it in 6 quarters.
UBS O'Connor's 89bio position peaked at $1.59M in Q2 2023.
145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.